ENTITY

Argenx SE (ARGX US)

44
Analysis
Health CareNetherlands
argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.
more
Company Event27 Feb 2025 16:00 • Upcoming
Add To Calendar
Company Event31 Oct 2024 20:30 • Latest
Company Event25 Jul 2024 20:30
Company Event16 Jul 2024 20:30
x